BCC Research
BCC Research

SYSTEM BIOSCIENCES LLC

Company Snapshot

Founded: 2004
Entity Type: Private
Region: U.S.
Headquarter: California, U.S.
Key Geographics: U.S.

Company Overview

System Biosciences LLC. (SBI) specializes in developing unique, innovative technologies to provide researchers with the tools to investigate molecular and cell biology, such as tools for exosome research, vector delivery technologies, microRNA research, and genome engineering tools.

SBI developed an extensive portfolio of tools and reagents for exosome research, including exosome isolation, detection, quantitation, labeling, biomarker profiling, engineering, and design.  It offers NGS platforms, mass spectrometry, and engineering tools for exosome research, along with antibodies, kits, and purified exosomes.

SYSTEM BIOSCIENCES LLC In Reports

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

BCC Research Market Report provides an overview of Exosome Diagnostics and Therapeutics Market scope of the study is global. Current and projected market forecasts during the forecast period (2023 to 2028).

Induced Pluripotent Stem Cells: Global Markets

BCC Research Market Report says global market for induced pluripotent stem cells is expected to grow from $3.4 billion in 2023 and forecast to reach $5.2 billion by the end of 2028 at a CAGR of 9.1%.

Genome Editing: Technologies and Global Markets

Global genome editing market should reach $12.8 billion by 2027 from $4.3 billion in 2022 at a CAGR of 24.7% for the forecast period of 2022-27.

View All Reports

SYSTEM BIOSCIENCES LLC In News

Exosome Research Market worth US$480.6 million by 2030 with 17.5% CAGR | MarketsandMarkets™ - Barchart.com

Barchart.com - Jul 09, 2025

Emalex Biosciences Announces $250 Million Financing Round to Advance Investigational New Drug for Tourette Syndrome - Bain Capital

Bain Capital - Jun 26, 2025

Sentio BioSciences Builds Health and Hope in St. Louis - St. Louis Economic Development Partnership

St. Louis Economic Development Partnership - May 15, 2025

VION Biosciences Acquires Enzymatic Assay Innovator BioAssay Systems - Business Wire

Business Wire - Feb 05, 2025

Read All News

Company's Business Segments

  • Products : The company generates revenue from several product categories such as, Exosome Research, CRISPR/Cas9 Systems, Lentivirus Production, Gene Expression Systems, Imaging and Reporter Vectors, miRNA and IncRNA Research Tools, Liquid Biopsy Research, Covid-19 Research Tools.
  • Services : The company generates revenue by providing various services such as Custom Services, Exsome Services, Syn2Clone Custome Constructs, Lentivirus Packaging, Stable Cell Lines, RNA Services, Minicircle Services, CRISPR/Cas9 Services.

Applications/End User Industries

  • Biotechnology
  • Cancer Research
  • Genomics
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

Contact

© 2025 BCC Research

Privacy Policy |Site Map|Terms & Conditions